Full Spectrum Astragalus Extract 500 mg

Full Spectrum Astragalus Extract 500 mg

Planetary Herbals4.7 (534 ratings)
Format:Tablet Quantity: 120 Tablet(s) · 60 servings
Goals
$13.30 $0.22 per serving

Product analysis

51 out of 100

Full Spectrum Astragalus Extract 500 mg is intended for traditional immune support, with routine infection-related benefits remaining uncertain. The unspecified preparation makes it difficult to judge how it compares with other astragalus extracts.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The ingredient forms are not specified, including the astragalus preparation. Their quality cannot be judged confidently from the available information.

Ingredient Transparency63

Amounts are stated for the ingredients. Their forms are omitted, so the exact preparations remain unclear.

Value For Money40

Value for money remains uncertain across the formula. There is not enough information for a reliable comparison of ingredient contributions and serving cost.

Customer Satisfaction77

Customer feedback is highly positive across hundreds of ratings. The response count provides useful context for satisfaction.

Product Focus84

Astragalus has traditional immune uses, but reliable routine adult infection benefits are not established. An unspecified preparation also prevents a clear match to a supported amount.

Format
Tablet
Container
120 Tablet(s)
Per serving
$0.22
Customer rating
4.7 · 534 ratings
Report analysis

Goals

Immunity
Impact
Highest effect
A- Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic

Astragalus has traditional immune uses, but reliable routine adult infection outcomes and a transferable preparation-specific amount are not established.

How this product is rated for Immunity

Ingredient fit86

Astragalus provide the main immune-related focus, alongside other actives with less direct relevance. The included amounts fully meet the saved amount comparison; this does not establish extra benefits above nutritional adequacy.
Goal fit
Astragalus provide the main immune-related focus, alongside other actives with less direct relevance.
Dose adequacy
The included amounts fully meet the saved amount comparison; this does not establish extra benefits above nutritional adequacy.

Pathways57

The strongest area is innate immune cell activity, with partial coverage from the relevant ingredients.
Depth
The strongest area is innate immune cell activity, with partial coverage from the relevant ingredients.
Breadth
The areas reaching the saved coverage threshold are innate immune cell activity.

Evidence95

Astragalus leads the saved evidence comparison; its population and preparation limitations prevent broad immune-protection claims.
Evidence strength
Astragalus leads the saved evidence comparison; its population and preparation limitations prevent broad immune-protection claims.
Studied preparation
The eligible preparations match those accepted in the saved findings, without implying superior forms or broader clinical benefits.

Formulation logic100

None of the evaluated ingredient conflicts was triggered. The relevant ingredients can contribute independently or have their required partner present; no extra combined effect is established.
Partner coverage
The relevant ingredients can contribute independently or have their required partner present; no extra combined effect is established.
Conflicts
None of the evaluated ingredient conflicts was triggered.
Effective doses
All included ingredients meet the saved minimum amount comparison; this is not itself a clinically proven effectiveness threshold.
Study evidence
Astragalus Supportive 16 studies

Ingredients

IngredientAmount per servingScore
Total Carbohydrates
1 Gram(s)
Calcium
65 mg
Astragalus root extract
500 mg 100
Astragalus
500 mg 100
Adults 18–50
Report overview
Astragalus · 500 mg OverallScore100
A+ Composition And Label Disclosure
A serving lists 1000 mg of astragalus. The disclosed amount makes it possible to compare how much is in each serving.
How this ingredient is rated

Composition and Label Disclosure

No separate preparation assessment was made.

Composition and Label Disclosure100

The astragalus amount is disclosed as 1000 mg per serving.
Individual Preparation Amount Disclosure
The individual astragalus amount is listed as 1000 mg per serving.

Commercial Price and Usability

No price comparison was evaluated.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies.
    Sun T; Zhao R; Zhang Y; Li D; Shan X; Tang X; Zheng Y · Frontiers in pharmacology · 2025
    Meta-analysis776 participants9 studies pooledImmunity forAstragalus
  2. [Effect of intravenous drip infusion of cyclophosphamide with high-dose Astragalus injection in treating lupus nephritis].
    Su L; Mao JC; Gu JH · Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine · 2008
    Randomized trial43 participantsImmunity forAstragalus
  3. Astragalus mongholicus (Fisch.) Bge Improves Peripheral Treg Cell Immunity Imbalance in the Children With Viral Myocarditis by Reducing the Levels of miR-146b and miR-155.
    Zhang Z; Dai X; Qi J; Ao Y; Yang C; Li Y · Frontiers in pediatrics · 2020
    Randomized trial68 participantsImmunity forAstragalus
  4. [Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor].
    Duan P; Wang ZM · Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine · 2003
    Randomized trial120 participantsImmunity forAstragalus
  5. [Modulatory effect of Astragalus membranaceus on Th1/Th2 cytokine in patients with herpes simplex keratitis].
    Mao SP; Cheng KL; Zhou YF · Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine · 2004
    Randomized trial168 participantsImmunity forAstragalus